Feasibility of Long-term, High-dose Stimulant for Methamphetamine Use Disorder

Abroad (travel likely)RecruitingPHASE2

Conditions

Methamphetamine Abuse · Methamphetamine-dependence · Addiction · Substance Abuse · Methamphetamine Use Disorder

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Centre hospitalier de l'Université de Montréal (CHUM), Montreal, Quebec, Canada
Contact: Study coordinator (Amina Sow, Ph.D) · amina.sow.chum@ssss.gouv.qc.ca · 438-860-2452
Contact: Study coordinator (Heidar Sharafi, Ph.D) · heidar.sharafi.chum@ssss.gouv.qc.ca

Study leads

Didier Jutras-Aswad, MD
Principal Investigator
CHUM

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Clinical Trial of High Dose Lisdexamfetamine and Contingency Management in MA Users

Methamphetamine Abuse · Methamphetamine-dependence · Addiction, Substance

Abroad (travel likely)RecruitingPHASE2

Vancouver, Canada · Fredericton, Canada

Encouraging Abstinence Behavior in a Drug Epidemic: Optimizing Dynamic Incentives

Opioid-use Disorder · Cocaine Use Disorder · Opioid Use

Abroad (travel likely)Recruiting

Oconomowoc, United States · Wauwatosa, United States

A Single-Dose Study to Evaluate Safety and Efficacy of CS-1103 in Participants Receiving a Single Dose of Methamphetamine

Methamphetamine Intoxication · Methamphetamine Disorders · Methamphetamine Abuse

Abroad (travel likely)RecruitingPHASE2

Glendale, United States

Ketamine for Methamphetamine Use Disorder

Substance Use Disorders · Substance Use · Methamphetamine Abuse

Abroad (travel likely)RecruitingPHASE2

San Leandro, United States · Albuquerque, United States